Influenza virus proton channels
… The ion channel for the influenza A virus, but not influenza B virus, is inhibited by the antiviral
… from influenza A virus, is the target for action of the antiviral drug amantadine. Thus, these …
… from influenza A virus, is the target for action of the antiviral drug amantadine. Thus, these …
The host interactome of influenza virus presents new potential targets for antiviral drugs
ML Shaw - Reviews in medical virology, 2011 - Wiley Online Library
… Amantadine and rimantadine both target the M2 protein and are specific for influenza A
virus. By inhibiting M2 ion channel activity, they block acidification of the incoming virus particle …
virus. By inhibiting M2 ion channel activity, they block acidification of the incoming virus particle …
Overview of HCV life cycle with a special focus on current and possible future antiviral targets
N Alazard-Dany, S Denolly, B Boson, FL Cosset - Viruses, 2019 - mdpi.com
… assemble to form ion channel structures and was … of antiviral targets, with an increasing
number of such proteins described and characterized, and the success of using host ion channel …
number of such proteins described and characterized, and the success of using host ion channel …
Structural and functional properties of the hepatitis C virus p7 viroporin
V Madan, R Bartenschlager - Viruses, 2015 - mdpi.com
… led to the development of curative antiviral therapy. Moreover, … inhibitors for antagonizing p7
ion channel/pore-like activity. … disruption of ionic gradients across target membranes thereby …
ion channel/pore-like activity. … disruption of ionic gradients across target membranes thereby …
Entry of influenza A virus: host factors and antiviral targets
TO Edinger, MO Pohl, S Stertz - Journal of General …, 2014 - microbiologyresearch.org
… Here, we review entry of this important pathogen into target cells, an essential process by …
the first essential step of virus replication and is an ideal target to block infection efficiently. …
the first essential step of virus replication and is an ideal target to block infection efficiently. …
Controlling influenza virus replication by inhibiting its proton channel
… ion channels known as A/M2 and BM2, respectively. The A/M2 channel is the target of the
antiviral … of proton conductance of the viral ion channels are described and the review makes a …
antiviral … of proton conductance of the viral ion channels are described and the review makes a …
Baloxavir marboxil: the new influenza drug on the market
R O'Hanlon, ML Shaw - Current opinion in virology, 2019 - Elsevier
… were the adamantanes or M2 ion channel inhibitors and the … and they act by blocking the
M2 ion channel activity (for influenza A … function would be a good antiviral target [25]. However, …
M2 ion channel activity (for influenza A … function would be a good antiviral target [25]. However, …
Coexistence of two adamantane binding sites in the influenza A M2 ion channel
MR Rosenberg, MG Casarotto - Proceedings of the …, 2010 - National Acad Sciences
… ion channel (M2) that is the target of the adamantane family of drug inhibitors. Two recently
published studies relating to adamantane binding of the M2 ion channel … of antiviral drugs …
published studies relating to adamantane binding of the M2 ion channel … of antiviral drugs …
Influenza virus M2 protein has ion channel activity
… 7 indicated that the target of antiviral action is the hydropho… ion channel activity. The
concentrations of the drug used to … in testing the associated ion channel activity of MP proteins …
concentrations of the drug used to … in testing the associated ion channel activity of MP proteins …
Structure‐guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion release
TL Foster, GS Thompson, AP Kalverda… - …, 2014 - Wiley Online Library
… ion channel, or “viroporin,” whose essential functions represent a clinically proven class of
antiviral target … Specific drug-protein interactions validate an allosteric site on the channel …
antiviral target … Specific drug-protein interactions validate an allosteric site on the channel …